Alternating recombinant and natural alpha-interferon helps to prevent clinical resistance to interferon in cutaneous T-cell lymphoma treatment
DOI: 10.1080/000155598433638
Abstract
This article does not have an abstract.
Significance
Supplementary content
Comments
